AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Annovis Bio, Inc. Director's Dealing 2021

Apr 19, 2021

34695_dirs_2021-04-19_3c7bed1e-e2dd-4195-afc1-0ca257f7f629.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Annovis Bio, Inc. (ANVS)
CIK: 0001477845
Period of Report: 2021-04-09

Reporting Person: McCarthy Reid (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, $0.0001 par value	6329	Direct